Your browser doesn't support javascript.
loading
Application and prospect of cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy in the treatment of peritoneal metastasis from colorectal cancer / 中华肿瘤杂志
Chinese Journal of Oncology ; (12): 73-78, 2022.
Article in Chinese | WPRIM | ID: wpr-935184
ABSTRACT
Colorectal cancer is one of the common malignant tumors in China, and its incidence is increasing with years. As the second most common metastatic site of colorectal cancer, peritoneum is difficult to diagnose early and with a poor prognosis. Systemic intravenous chemotherapy was used as the main treatment strategy for peritoneal metastasis in the past, but its systemic toxic and side effects were obvious, and it could not effectively control tumor progression. In recent years, the continuous development of surgical techniques, concepts, and equipment, as well as the introduction of new chemotherapy drugs and targeted drugs have significantly improved the quality of life and prognosis of patients with peritoneal metastasis of colorectal cancer. Cytoreductive surgery (CRS) combined with hyperthermic intraperitoneal chemotherapy (HIPEC) can effectively eradicated the intraperitoneal free cancer cells and subclinical lesions, while reducing systemic side effects of chemotherapy drugs, and achieve the radical cure of the tumor at the macro and micro levels to the greatest extent. It has been used as the first-line treatment program for peritoneal metastasis of colorectal cancer at home and abroad. This article focuses on the analysis and summary of the survival efficacy, prognostic factor analysis, and chemotherapy safety of CRS+ HIPEC in the treatment of colorectal cancer peritoneal metastasis. The existing problems and controversies of HIPEC therapy are discussed simultaneously.
Subject(s)

Full text: Available Index: WPRIM (Western Pacific) Main subject: Peritoneal Neoplasms / Peritoneum / Prognosis / Quality of Life / Colorectal Neoplasms / Antineoplastic Combined Chemotherapy Protocols / Survival Rate / Combined Modality Therapy / Cytoreduction Surgical Procedures / Hyperthermic Intraperitoneal Chemotherapy Type of study: Prognostic study Limits: Humans Language: Chinese Journal: Chinese Journal of Oncology Year: 2022 Type: Article

Similar

MEDLINE

...
LILACS

LIS

Full text: Available Index: WPRIM (Western Pacific) Main subject: Peritoneal Neoplasms / Peritoneum / Prognosis / Quality of Life / Colorectal Neoplasms / Antineoplastic Combined Chemotherapy Protocols / Survival Rate / Combined Modality Therapy / Cytoreduction Surgical Procedures / Hyperthermic Intraperitoneal Chemotherapy Type of study: Prognostic study Limits: Humans Language: Chinese Journal: Chinese Journal of Oncology Year: 2022 Type: Article